XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Statements Of Cash Flows - USD ($)
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash Flows from Operating Activities:    
Net income (loss) $ 2,828,701 $ (570,322)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest earned on marketable securities held in Trust Account (5,279,395) (1,546,474)
Unrealized loss on marketable securities held in Trust Account 0 0
Compensation expenses 0 362,500
Changes in operating assets and liabilities:    
Prepaid expenses 272,145 (489,935)
Accrued expenses (528,026) 893,916
Income taxes payable 1,200,013 293,453
Net cash used in operating activities (1,506,562) (1,056,862)
Cash Flows from Investing Activities:    
Investment of cash into Trust Account 0 (306,000,000)
Cash withdrawn from Trust Account to pay franchise and income taxes 2,132,269 0
Cash withdrawn from Trust Account in connection with redemption 276,471,460 0
Net cash provided by (used in) investing activities 278,603,729 (306,000,000)
Cash Flows from Financing Activities:    
Proceeds from sale of Units, net of underwriting discounts paid 0 294,240,000
Proceeds from sale of Private Placement Warrants 0 13,850,000
Proceeds from promissory note – related party 0 49,262
Repayment of promissory note – related party 0 (149,539)
Payment of offering costs (70,000) (743,830)
Redemption of common stock (276,471,460) 0
Net cash (used in) provided by financing activities (276,541,460) 307,245,893
Net Change in Cash 555,707 189,031
Cash – Beginning of period 392,446 0
Cash – End of period 948,153 189,031
Non-cash investing and financing activities:    
Offering costs included in accrued offering costs 0 717,219
Initial classification of Series A common stock subject to possible redemption 0 307,103,021
Remeasurement of carrying value to redemption value 3,942,803 0
Deferred underwriting fee payable $ 0 $ 10,500,000